We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.
Product defect recall alert for Kelactin 50 Microgram/ml Oral Solution for Dogs and Cats and PGF Veyx Forte 0.250mg/ml Solution for Injection for Cattle and Pigs by Veyx-Pharma GmbH.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 15 July 2025, approved sebetralstat (Ekterly) for the treatment of hereditary angioedema (HAE) attacks in adults and adolescents aged 12 years and older.
Protected food name with Protected Designation of Origin (PDO)
Product recall for Salsa Cycles Cowbell Carbon Cowchipper Carbon Handlebars presenting a risk of injuries.
Change to the information provided on adverse events in the Summary of Product Characteristics for Credelio 12mg and 48mg chewable tablets for cats.
Protected wine name with Protected Geographical Indication (PGI)
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).